Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Humanigen Inc
(NQ:
HGEN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jul 25, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Humanigen Inc
< Previous
1
2
3
4
5
6
Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 01, 2021
Gainers Paratek Pharmaceuticals (NASDAQ:PRTK) stock increased by 12.65% to $9.26 during Tuesday's pre-market session. The company's market cap stands at $434.5...
Via
Benzinga
24 Stocks Moving in Tuesday's Pre-Market Session
June 01, 2021
Gainers Vertex Energy, Inc. (NASDAQ: VTNR) rose 43.5% to $11.21 in pre-market trading. Vertex Energy, shares jumped around 96% on Friday on continued momentum after the company...
Via
Benzinga
44 Biggest Movers From Friday
June 01, 2021
Gainers Vertex Energy, Inc. (NASDAQ: VTNR) shares jumped 95.7% to close at $7.81 on continued momentum after the company announced it will acquire an Alabama refinery and related...
Via
Benzinga
38 Stocks Moving In Friday's Mid-Day Session
May 28, 2021
Gainers Vertex Energy, Inc. (NASDAQ: VTNR) shares surged 48.6% to $5.93 on continued momentum after the company announced it will acquire an Alabama refinery and related...
Via
Benzinga
Humanigen Files US Emergency Use Application For Lenzilumab For COVID-19
May 28, 2021
Humanigen Inc (NASDAQ: HGEN) has submitted an application to the FDA seeking Emergency Use Authorization (EUA) for lenzilumab to treat patients hospitalized with...
Via
Benzinga
Exposures
Product Safety
Humanigen Recruits Chime Biologics As Manufacturing Partner For Lenzilumab
May 17, 2021
Humanigen Inc (NASDAQ: HGEN) and Chime Biologics, contract development and manufacturing organization (CDMO), have entered into a manufacturing services...
Via
Benzinga
Humanigen Shares Gain On FDA Emergency Filing Plans For COVID-19 Drug By June
May 14, 2021
Humanigen Inc (NASDAQ: HGEN) is prepping its COVID-19 drug lenzilumab for an emergency use authorization with the FDA before the month’s end. According to its...
Via
Benzinga
Exposures
COVID-19
Product Safety
74 Biggest Movers From Friday
May 17, 2021
Gainers MoSys, Inc. (NASDAQ: MOSY) shares climbed 50.5% to settle at $4.35 on Friday. MoSys, last week, reported a loss for its first quarter. HyreCar Inc. (NASDAQ: HYRE) shares...
Via
Benzinga
28 Stocks Moving in Friday's Pre-Market Session
May 14, 2021
Gainers BIOLASE, Inc. (NASDAQ: BIOL) shares rose 28.5% to $0.7451 in pre-market trading after the company reported better-than-expected Q1 sales. Bionano Genomics, Inc. (NASDAQ:...
Via
Benzinga
54 Stocks Moving In Friday's Mid-Day Session
May 14, 2021
Gainers HyreCar Inc. (NASDAQ: HYRE) shares jumped 44.5% to $12.93 after the company reported Q1 results. MoSys, Inc. (NASDAQ: MOSY) shares jumped 39.8% to $4.04. MoSys, last week...
Via
Benzinga
Review Of Present Therapies For Covid-19
May 09, 2021
A summary of authorized drugs for Covid-19, those in development, and those that have failed.
Via
Talk Markets
Exposures
COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For May 7, 2021
May 07, 2021
Upgrades Loop Capital upgraded the previous rating for Roku Inc (NASDAQ:ROKU) from Hold to Buy. In the first quarter, Roku showed an EPS of $0.54, compared to $0.45 from...
Via
Benzinga
This Biotech Stock Could See A Big Move If It Breaks Out Of The Pennant It's Forming
May 05, 2021
Humanigen Inc. (NASDAQ: HGEN) shares made gains Wednesday following the publication of results from a Phase 3 randomized double-blind placebo-controlled study. The...
Via
Benzinga
Why Humanigen Stock Vaulted Higher Today
May 05, 2021
Detailed results from a late-stage study of the company's lead candidate were published online.
Via
The Motley Fool
Exposures
COVID-19
52 Biggest Movers From Yesterday
May 04, 2021
Gainers Regional Health Properties, Inc. (NYSE: RHE) shares climbed 102.5% to close at $14.62 on Monday after jumping 38% on Friday. Image Sensing Systems, Inc. (NASDAQ: ISNS)...
Via
Benzinga
32 Stocks Moving In Monday's Mid-Day Session
May 03, 2021
Gainers Regional Health Properties, Inc. (NYSE: RHE) shares jumped 99.7% to $14.42 after jumping 38% on Friday. Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) gained 30.5% to $64....
Via
Benzinga
Mid-Morning Market Update: Markets Open Higher; Estée Lauder Reports Mixed Q3 Results
May 03, 2021
Following the market opening Monday, the Dow traded up 0.80% to 34,147.27 while the NASDAQ rose 0.54% to 14,038.00. The S&P also rose, gaining 0.65% to 4,208.31. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
3 Popular Reddit Biotech Stocks That You Should Avoid
May 01, 2021
We think speculative Reddit biotech stocks Ocugen, Inc. (OCGN), Humanigen Inc. (HGEN), and 180 Life Sciences Corp. (ATNF) should be avoided at all costs given questions about their prospects or ability...
Via
Talk Markets
The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue
April 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 20) Alexion Pharmaceuticals,...
Via
Benzinga
Humanigen's Lenzilumab Shows Encouraging Response Rate In Blood Cancer Study
April 19, 2021
Humanigen Inc (NASDAQ: HGEN) has announced data from the Phase 1b portion of the ZUMA-19 trial evaluating its lead candidate lenzilumab in patients...
Via
Benzinga
Cramer Weighs In On Paysafe, Xilinx And More
April 15, 2021
On CNBC's "Mad Money Lightning Round," Jim Cramer said Keysight Technologies Inc (NYSE: KEYS) has been just red hot and he really likes it. Amarin Corporation plc (...
Via
Benzinga
Could These 2 Exciting COVID Stocks be 10-Baggers?
April 11, 2021
They're approaching the treatment-race finish line.
Via
The Motley Fool
Exposures
COVID-19
Humanigen's Ifabotuzumab Shows Encouraging Action In Early-Stage Brain Cancer Study
April 09, 2021
Humanigen Inc (NASDAQ: HGEN) has announced results from the Phase 1 trial evaluating its second Humaneered antibody, ifabotuzumab, in patients with...
Via
Benzinga
30 Stocks Moving in Friday's Pre-Market Session
April 09, 2021
Gainers Celcuity Inc. (NASDAQ: CELC) rose 32.3% to $19.00 in pre-market trading after the company reported a worldwide licensing agreement with Pfizer to develop and...
Via
Benzinga
Could Humanigen Stock Soar Even Higher After Its COVID Antibody Results?
April 08, 2021
It's a definite maybe.
Via
The Motley Fool
Exposures
COVID-19
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.